论文部分内容阅读
分别合成了 [Co(3, 3-tri)(men)Cl][ZnCl4]、[Co(3, 3-tri)(cmen)Cl][ZnCl4] (3, 3-tri = N-(3-胺基丙基)-1, 3-丙二胺,men = N-甲基乙二胺,cmen = 1, 2-二胺基-丙烷) 2体系的部分配合物异构体,用单晶 X-射线衍射分析方法解析了2异构体的晶体结构。其中 [Co(3, 3-tri)(men)Cl][ZnCl4] 体系的一异构体Ⅰ的化学简式为 CoCl(C9H27N5)ZnCl4,晶体属正交晶系,空间群 Pca21,a = 16.788(2),b = 7.964(1),c = 14.416(2) 牛琕 =1927.3(4) ?,Dc = 1.747 g/cm3,Z = 4,F(000) = 1032,Mr = 506.91,R = 0.0352,wR =0.0935;[Co(3, 3-tri)(cmen)Cl]2+ 体系的一异构体Ⅱ的化学简式为 CoCl(C9H27N5)ZnCl4稨2O, 晶体属三斜晶系,空间群 P ,a = 9.511(3), b = 9.972(3),c = 11.694(3) 牛琣 = 68.367(5),b = 85.196(6),?= 86.580(5),V = 1026.9(5)?3,Dc = 1.698 g/cm3,Z = 2,F(000) = 536,Mr = 524.92,R = 0.0494,wR = 0.1180。两异构体中 Co3+ 为六配位,晶胞中对映体比例均为1:1。在配合物异构体Ⅰ和Ⅱ中,三元胺以经式排布,三元胺配体(3, 3-tri)仲胺上的氢相对于Cl分别处于顺位(syn-)和反位(anti-);二元胺配体氮(或邻位碳)取代的胺基氮原子(N*)与三元胺配体中的仲氮原子分别处于对位(trans(N*))和邻位(cis(N*))。
[Co (3, 3-tri) (men) Cl] [ZnCl4], [Co (3,3- tri) (cmen) Cl] [ZnCl4] Aminopropyl) -1,3-propanediamine, men = N-methylethylenediamine, cmen = 1,2-diamino-propane) 2 system, - X-ray diffraction analysis of the crystal structure of 2 isomers. The chemical formula I of the isomer I of [Co (3, 3-tri) (men) Cl] [ZnCl4] system is CoCl (C9H27N5) ZnCl4 with orthorhombic crystal system, space group Pca21, a = 16.788 (2), b = 7.964 (1), c = 14.416 (2) 琕 琕 = 1927.3 (4), Dc = 1.747 g / cm3 Z = 4 F = 00032 = Mr = 506.91 R = 0.0352, wR = 0.0935. The chemical formula of one isomer II of Co (3, 3-tri) (cmen) Cl] 2+ system is CoCl (C9H27N5) ZnCl4 稨 2O. Group P = a = 9.511 (3) b = 9.972 (3) c = 11.694 (3) Cattle 琣 = 68.367 (5) b = 85.196 (6) = 86.580 (5) V = 1026.9 )? 3, Dc = 1.698 g / cm3, Z = 2, F (000) = 536, Mr = 524.92, R = 0.0494, wR = 0.1180. In the two isomers, Co3 + is hexacoordinated and the enantiomeric ratio in the unit cell is 1: 1. In the complex isomers I and II, the triamines are formally arranged and the hydrogen on the secondary amine of the triamine ligand (3, 3-tri) is in syn- and anti (Trans (N *)) of the amino nitrogen atom (N *) substituted with the diamine ligand nitrogen (or ortho carbon) and the secondary nitrogen atom in the triamine ligand, respectively And cis (cis (N *)).